4BB: Revenue growth expectations based on inflecting pipeline

Research evidence excerpt

4BB: Revenue growth expectations based on inflecting pipeline

4basebio PLC

Key sustainability questions

This section is intended to highlight key sustainability discussion points relevant to this company, as well as our views on the outlook. Both the

questions we highlight and our responses will evolve over time as the dialogue between management, analysts and investors continues to

advance. We welcome any feedback on the topics.

Our view

What are the most material People strategy remains the most material sustainability factor for 4basebio. With

Sustainability issues facing this headcount growing from approximately 100 to approximately 145 FTEs during

company? 2025, hiring and retaining specialist scientists and commercial staff in enzymatic

DNA manufacturing is critical to maintaining its competitive positioning as the

leading cell-free synthetic DNA provider. Manufacturing volumes remain measured

in milligrams to grams, limiting near-term environmental materiality, though scaling

GMP production across seven clean rooms may increase energy intensity over time.

The company does not conduct a formal materiality assessment.

Does the company integrate 4basebio's 10 corporate governance principles include commitments to "take into

Sustainability considerations into its account wider stakeholder and social responsibilities" and to "promote a corporate

strategy? culture based on ethical values and behaviours". The Board does not operate a

dedicated sustainability committee; governance oversight sits with the full Board.

There are no sustainability metrics linked to executive compensation. The company

does not report under TCFD, GRI, or SBTi frameworks, nor does it disclose Scope 1,

2, or 3 emissions in its Annual Report.